Salmonella infection of breast implant associated with traveler's diarrhea: A case report

Bradley R. Hall, Katherine L. Billue, Stacey E. Sanders, Bria R. Meyer, Perry James Johnson

Research output: Contribution to journalArticle

Abstract

We present the first case of traveler's diarrhea resulting in breast implant infection. An otherwise healthy 34-year-old female underwent breast augmentation. Five months later, while vacationing in Cancun, Mexico, she developed abdominal pain and diarrhea that progressed to include fevers and chills. Her symptoms persisted until she returned to the United States, at which point her primary care physician evaluated her on the fourth day of her illness. An abdominal CT scan was unremarkable; however, a complete metabolic panel demonstrated elevated transaminases. Her symptoms soon resolved without treatment. Fourteen days after symptom resolution, the patient developed right breast pain. She was evaluated in the surgical clinic where the breast was tender to palpation, swollen and without erythema. An ultrasound demonstrated a small amount of homogenous fluid surrounding the implant. She was prescribed amoxicillin–clavulanate 875–125 mg BID; however, she presented three days later with worsening pain, swelling and new erythema. She was taken to the operating room, where the abscess was incised, drained and the implant removed. Cultures grew Salmonella serogroup C. Patients should be counseled regarding the potential for hematogenous seeding of the breast cavity and implant following severe illness and bacteremia. It may be reasonable to provide patients with breast implants who are traveling to areas at high-risk for traveler's diarrhea or areas with limited medical resources with an antibiotic to take if moderate to severe symptoms of traveler's diarrhea were to develop while away.

Original languageEnglish (US)
Pages (from-to)59-64
Number of pages6
JournalJPRAS Open
Volume18
DOIs
StatePublished - Dec 2018

Fingerprint

Breast Implants
Salmonella Infections
Diarrhea
Erythema
Breast
Point-of-Care Systems
Mastodynia
Chills
Sick Leave
Palpation
Primary Care Physicians
Patient Rights
Operating Rooms
Bacteremia
Mexico
Transaminases
Salmonella
Abscess
Abdominal Pain
Fever

Keywords

  • Breast
  • Implant
  • Infection
  • Salmonella
  • Traveler's diarrhea

ASJC Scopus subject areas

  • Surgery

Cite this

Salmonella infection of breast implant associated with traveler's diarrhea : A case report. / Hall, Bradley R.; Billue, Katherine L.; Sanders, Stacey E.; Meyer, Bria R.; Johnson, Perry James.

In: JPRAS Open, Vol. 18, 12.2018, p. 59-64.

Research output: Contribution to journalArticle

Hall, Bradley R. ; Billue, Katherine L. ; Sanders, Stacey E. ; Meyer, Bria R. ; Johnson, Perry James. / Salmonella infection of breast implant associated with traveler's diarrhea : A case report. In: JPRAS Open. 2018 ; Vol. 18. pp. 59-64.
@article{e087fc2d56974dea81901f833b7a8530,
title = "Salmonella infection of breast implant associated with traveler's diarrhea: A case report",
abstract = "We present the first case of traveler's diarrhea resulting in breast implant infection. An otherwise healthy 34-year-old female underwent breast augmentation. Five months later, while vacationing in Cancun, Mexico, she developed abdominal pain and diarrhea that progressed to include fevers and chills. Her symptoms persisted until she returned to the United States, at which point her primary care physician evaluated her on the fourth day of her illness. An abdominal CT scan was unremarkable; however, a complete metabolic panel demonstrated elevated transaminases. Her symptoms soon resolved without treatment. Fourteen days after symptom resolution, the patient developed right breast pain. She was evaluated in the surgical clinic where the breast was tender to palpation, swollen and without erythema. An ultrasound demonstrated a small amount of homogenous fluid surrounding the implant. She was prescribed amoxicillin–clavulanate 875–125 mg BID; however, she presented three days later with worsening pain, swelling and new erythema. She was taken to the operating room, where the abscess was incised, drained and the implant removed. Cultures grew Salmonella serogroup C. Patients should be counseled regarding the potential for hematogenous seeding of the breast cavity and implant following severe illness and bacteremia. It may be reasonable to provide patients with breast implants who are traveling to areas at high-risk for traveler's diarrhea or areas with limited medical resources with an antibiotic to take if moderate to severe symptoms of traveler's diarrhea were to develop while away.",
keywords = "Breast, Implant, Infection, Salmonella, Traveler's diarrhea",
author = "Hall, {Bradley R.} and Billue, {Katherine L.} and Sanders, {Stacey E.} and Meyer, {Bria R.} and Johnson, {Perry James}",
year = "2018",
month = "12",
doi = "10.1016/j.jpra.2018.08.004",
language = "English (US)",
volume = "18",
pages = "59--64",
journal = "JPRAS Open",
issn = "2352-5878",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Salmonella infection of breast implant associated with traveler's diarrhea

T2 - A case report

AU - Hall, Bradley R.

AU - Billue, Katherine L.

AU - Sanders, Stacey E.

AU - Meyer, Bria R.

AU - Johnson, Perry James

PY - 2018/12

Y1 - 2018/12

N2 - We present the first case of traveler's diarrhea resulting in breast implant infection. An otherwise healthy 34-year-old female underwent breast augmentation. Five months later, while vacationing in Cancun, Mexico, she developed abdominal pain and diarrhea that progressed to include fevers and chills. Her symptoms persisted until she returned to the United States, at which point her primary care physician evaluated her on the fourth day of her illness. An abdominal CT scan was unremarkable; however, a complete metabolic panel demonstrated elevated transaminases. Her symptoms soon resolved without treatment. Fourteen days after symptom resolution, the patient developed right breast pain. She was evaluated in the surgical clinic where the breast was tender to palpation, swollen and without erythema. An ultrasound demonstrated a small amount of homogenous fluid surrounding the implant. She was prescribed amoxicillin–clavulanate 875–125 mg BID; however, she presented three days later with worsening pain, swelling and new erythema. She was taken to the operating room, where the abscess was incised, drained and the implant removed. Cultures grew Salmonella serogroup C. Patients should be counseled regarding the potential for hematogenous seeding of the breast cavity and implant following severe illness and bacteremia. It may be reasonable to provide patients with breast implants who are traveling to areas at high-risk for traveler's diarrhea or areas with limited medical resources with an antibiotic to take if moderate to severe symptoms of traveler's diarrhea were to develop while away.

AB - We present the first case of traveler's diarrhea resulting in breast implant infection. An otherwise healthy 34-year-old female underwent breast augmentation. Five months later, while vacationing in Cancun, Mexico, she developed abdominal pain and diarrhea that progressed to include fevers and chills. Her symptoms persisted until she returned to the United States, at which point her primary care physician evaluated her on the fourth day of her illness. An abdominal CT scan was unremarkable; however, a complete metabolic panel demonstrated elevated transaminases. Her symptoms soon resolved without treatment. Fourteen days after symptom resolution, the patient developed right breast pain. She was evaluated in the surgical clinic where the breast was tender to palpation, swollen and without erythema. An ultrasound demonstrated a small amount of homogenous fluid surrounding the implant. She was prescribed amoxicillin–clavulanate 875–125 mg BID; however, she presented three days later with worsening pain, swelling and new erythema. She was taken to the operating room, where the abscess was incised, drained and the implant removed. Cultures grew Salmonella serogroup C. Patients should be counseled regarding the potential for hematogenous seeding of the breast cavity and implant following severe illness and bacteremia. It may be reasonable to provide patients with breast implants who are traveling to areas at high-risk for traveler's diarrhea or areas with limited medical resources with an antibiotic to take if moderate to severe symptoms of traveler's diarrhea were to develop while away.

KW - Breast

KW - Implant

KW - Infection

KW - Salmonella

KW - Traveler's diarrhea

UR - http://www.scopus.com/inward/record.url?scp=85054457227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054457227&partnerID=8YFLogxK

U2 - 10.1016/j.jpra.2018.08.004

DO - 10.1016/j.jpra.2018.08.004

M3 - Article

AN - SCOPUS:85054457227

VL - 18

SP - 59

EP - 64

JO - JPRAS Open

JF - JPRAS Open

SN - 2352-5878

ER -